What is AUPH's P/E ratio?

Aurinia Pharmaceuticals Inc (AUPH) currently trades at a P/E ratio of 6.47.

Aurinia Pharmaceuticals Inc reports a Return on Equity (ROE) of 52.54%.

What is AUPH's dividend yield?

Aurinia Pharmaceuticals Inc offers a dividend yield of 0.00%.

What is AUPH's Quality Score?

Our AI rates AUPH's overall financial quality at 100 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy AUPH?

Our AI Timing Score for AUPH is 26 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does AUPH belong to?

Aurinia Pharmaceuticals Inc is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange

Aurinia Pharmaceuticals Inc (AUPH) Stock Price

Stock Check Daily update data at 8:30 AM
(Price: 2026-07-31 | FS: 2026-03-31)

AUPH AI Analysis Summary

Our AI summary for AUPH: Aurinia Pharmaceuticals Inc (NASDAQ), Healthcare >> Biotechnology sector. The stock currently trades at a P/E of 6.47, ROE of 52.54%, a dividend yield of 0.00%. Its financial Quality Score stands at 100/100 — fundamentals stronger than most of the market. The AI Timing Score is 26/100 — most technical signals do not support an entry at this point. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

AUPH

Aurinia Pharmaceuticals Inc

US:NASDAQ STOCK Healthcare >> Biotechnology

USD 14.88

-0.12 (-0.80%) Day Change

Watchlist Portfolio Compare Chart

6.47

P/E

0.03

D/E

52.5%

ROE

41.2%

ROA

0.00%

Div Yield

AURINIA PHARMACEUTICALS INC
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 14.88 Price -0.12 (-0.80%) Day Change	NEWS SCORE: N/A

AUPH, the overall quality is excellent ( Quality = 100) but the timing to buy is ...(Sign In to See)...

Loading chart...

100 QUALITY

Signal: OUTPERFORM

Signal Description: Company financial health is Excellent

Reason: Company financial health is Excellent from almost all quality indicators

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

In details, quality factors are ok , financial health is not good , and ability to make profit is good , ...

Quality Factors

64%

In Recommendations?	In "Invest - GROWTH" Section
Select Rate	0.00 From 30 days period
Watch Rate	5.66 From 30 days period
News Score	N/A
Magic Formula Rank by ROA	82 GOOD
Magic Formula Rank by ROE	82 GOOD
Magic Formula Rank by ROIC	149
Price	14.88
PBV / Sector	3.40 / 5.20
Earning Per Share	2.30

PE / Sector	6.47 / 19.97 GREAT
PEG or PE/Growth / Sector	N/A / 1.22
Average 1M Daily Value	17.98 M GREAT
Average 1W Daily Value	18.93 M GREAT

Timing Factors

42%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

45%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Ability to Make Profit

72%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	99.97 / 98.71 GREAT
NPM Average (%) / Sector	15.74 / -1,721.76 GREAT
NPM Change Average (%) / Sector	973.96 / 5,211.62 GREAT
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	41.19 / 27.02 GREAT
ROA Average (%) / Sector	8.65 / -368.17
ROA Change Average (%) / Sector	855.14 / 5,404.12 GREAT
ROE (%) / Sector	52.54 / 3.47 GREAT
ROE Average (%) / Sector	11.23 / 6.51
ROE Change Average (%) / Sector	754.63 / 2,128.13 GREAT
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Return to Investors

Dividend (%) / Sector	N/A / 0.04
Dividend Average (%) / Sector	N/A / 17.04
Dividend Change Average (%) / Sector	N/A / -1.75

Registration Details

Analyze Date	2026-08-01 07:59:30
Symbol	AUPH
Name	AURINIA PHARMACEUTICALS INC
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	128.60 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	1,929.03 / 9,903.94

News, Concensus, ...

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: #140, 14315 ? 118 Avenue, Edmonton, AB, Canada, T5L 4S6

Phone: 250 744 2487

Website: https://www.auriniapharma.com

Employees: 128

Sector: Healthcare >> Biotechnology

Description: Aurinia Pharmaceuticals Inc., a biopharmaceutical company, engages in delivering therapies to people living with autoimmune diseases with high unmet medical needs in the United States and Japan. The company offers LUPKYNIS (voclosporin), an oral therapy for the treatment of adult patients with active lupus nephritis. It also develops aritinercept, a dual inhibitor of B cell-activating factor and proliferation-inducing ligand for the potential treatment of autoimmune diseases. The company was founded in 1993 and is headquartered in Edmonton, Canada.